508.460.8822 Contact Us

Industry News

The FDA has issued a revised draft guidance, “Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Products – Quality Considerations.” The agency is requesting for written comments to be submitted within 90 days to the Division of Dockets Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. The agency […]

Continue Reading

Proveris’ Senior Applications Chemist, Heli Chauhan, will be presenting a poster (Poster #25) titled “Impact of Actuator Design on Multi Dose Nasal Spray Characteristics.”  The Respiratory Drug Delivery Conference will be held from April 22nd through the 26th, 2018 at the JW Marriott Starr Pass Resort & Spa Tucson, Arizona. Please see our conference announcement […]

Continue Reading

 Marlborough, MA, March 27, 2018 – Proveris Scientific Corporation announces its participation in RDD (Respiratory Drug Delivery), a leading conference focusing on the development and commercialization of pulmonary and nasal pharmaceutical products. This five-day event will be held 22-26 April, 2018 at JW Marriott Starr Pass Resort & Spa Tucson, Arizona. Attendees at the conference […]

Continue Reading

Marlborough, MA, February 27, 2018 – Proveris Scientific announced today the spin-off of real-time, inhaler-specific voice guidance technology to Uneva Health, Inc. The technology is the core of a device/digital health platform Uneva Health is developing to reduce the enormous annual costs of inconsistent dosing caused by improper inhaler use while improving patient engagement and […]

Continue Reading

Marlborough, MA, February 1, 2018 – Proveris Scientific Corporation today announced Chip Leveille has been named President, effective immediately.  As President, Leveille will have responsibility for all areas of corporate operations including Sales, Marketing, Business Development, Support, Product Development, Quality, Operations, Finance and Human Resources.  He will report directly to Chief Executive Officer Dino Farina. […]

Continue Reading

Marlborough, MA, April 24, 2017 – Proveris Scientific Corporation, a leading organization engaged in advancing the science of nasal and inhaled drug delivery, has joined The International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) as an associate member. IPAC-RS is a highly respected technical resource and industry advocate for enhancing product quality for the […]

Continue Reading

Marlborough, MA, April 19, 2016 – Proveris Scientific Corporation announced today that the Company’s SprayVIEW® measurement system was used by Summit Biosciences during development of the first generic unit dose nasal spray product approved by the FDA. Approval of the abbreviated new drug application (ANDA) for Sumatriptan nasal spray USP, 5 mg and 20 mg […]

Continue Reading

Page 1 of 712345...Last »
 
"Proveris Scientific Corporation provides expert support for nasal developers. They are fast, reliable and are professionals at installing of their equipment and supports in demanding challenges." Dr. Peter Svete, Head of Physical Analytics, Lek Pharmaceuticals d.d.
 
 
"Proveris provides insightful and thorough test services. We would recommend working with Proveris. Proveris has great expertise in spray analysis." Elaine Schutte, Chief Development Officer, ProFibrix
 
 
"I want to express my sincere gratitude towards Proveris and the service team for being there to make sure our study goes well. The study just completed few minutes ago and thankfully everything went well.......while we conducted SAC study. It was a great display of professionalism by Proveris." ,
 
 
"As customary, Proveris's service team provided excellent service and was able to answer my questions." ,
 
 
"Thank you for the thorough training on our new equipment. I wish more companies would implement your hands on approach when it comes to training. Thanks again." ,
 
 
“We really appreciate the creativity and work conducted at Proveris for their Test Services (Proveris by Design®). Their knowledge, experience, and insight with OINDP’s was very helpful. Thanks to the Proveris team, we have a wonderful solution that we can use for commercial products!” Mic Iwashima, NDS Division, Shin Nippon Biomedical Laboratories, Ltd